Dave Muoio

By Dave Muoio 11:36 am September 2, 2020
Abbott announced yesterday that its recently cleared FreeStyle Libre 2 integrated continuous glucose monitoring (CGM) system is now covered by the Centers for Medicare and Medicaid Services (CMS), and available to Medicare beneficiaries with diabetes who meet eligibility criteria. Indicated for diabetes management in patients aged four years or older, the updated version of Abbott's system can...
By Dave Muoio 03:14 pm September 1, 2020
Apple and Google are refining their COVID-19 contact tracing framework to fast-track enrollment and, for Apple device owners, completely forego the need to download a separate app, representatives of the companies announced today. Launched today on iPhones with the iOS 13.7 update, "Exposure Notifications Express" sends device owners in participating states a push notification with the option to...
By Dave Muoio 11:15 am September 1, 2020
Hazel Health, a pediatric telehealth provider known for delivering care through school systems, has announced a $33.5 million Series C raise headed by Owl Ventures and Bain Capital Ventures. Uprising, Centene and UC San Francisco also invested in the round. WHAT IT DOES Through partnerships with school districts, Hazel Health operates virtual care clinics inside the school nurse's office. Its...
By Dave Muoio 03:04 pm August 31, 2020
Hogwash, or a brain activity breakthrough? Friday evening came with a long-awaited look at the work of Neuralink, Elon Musk's ambitious brain-computer interface implant startup. In the streamed progress update, Musk ran down a PowerPoint overview of the technology's capabilities, which he likened to "a Fitbit in your skull." The coin-shaped implant will read and wirelessly transmit brain signals...
By Dave Muoio 01:40 pm August 31, 2020
Pear Therapeutics highlighted data today from two studies of a digital cognitive behavioral therapy that acted as the precursor for Somryst, the prescription digital therapeutic for adults with chronic insomnia that was the first to pass through the FDA's Pre-Cert pilot pathway. The first, a randomized controlled trial of 1,149 Australian adults with insomnia and depressive symptoms, suggested...
By Dave Muoio 02:26 pm August 26, 2020
Stasis Labs announced today that its mobile-connected remote patient monitoring platform for hospital and outpatient use has launched in the U.S. The Stasis system is made up of a smart device, traditional vital sign sensors, a bedside monitor and supporting cloud platform. Through mobile, tablet or desktop apps, care teams can monitor their patients' conditions, review trends and receive...
By Dave Muoio 11:35 am August 26, 2020
Real-world evidence (RWE) technology startup Aetion has extended last year's $63 million Series B with a new $19 million raise. The funds come as strategic investments from Johnson & Johnson Innovation, JJDC, EDBI and Greenspring Associates, all three of which are new supporters of the company. WHAT IT DOES Founded in 2013, the company's platform provides insights from RWE to decision-makers...
By Dave Muoio 04:16 pm August 25, 2020
Less than half a year after closing a $75 million raise, digital behavioral health benefits platform Lyra Health has wrapped up another $110 million in Series D funding, the company announced today. The new round was led by Addition, and brought on Adams Street Partners alongside a slew of returning backers: Casdin Capital, Glynn Capital, Greylock, IVP, Meritech Capital Partners, Providence...
By Dave Muoio 02:28 pm August 25, 2020
Sonde Health, a PureTech Health spinout focused on vocal biomarkers for various health conditions, has acquired voice-based survey-platform-maker NeuroLex Laboratories, the companies announced this morning. The terms of the deal were not disclosed, although the companies noted that NeuroLex CEO Jim Schwoebel will be stepping into Sonde's executive team as its new VP of data and research. Sonde's...
By Dave Muoio 11:33 am August 25, 2020
The Consumer Technology Association (CTA) announced this morning a new group of 24 technology and digital health companies aiming to develop industry-wide standards for digital therapeutics use. Headlined by big names like Google Health, Doctor on Demand, HP, Livongo and ResMed (see below for the full list), the initiative is tackling the amorphous definitions and terminologies that abound within...